FDA Grants Full Final Approval To Moderna Vaccine

The Washington Post reports:

The Food and Drug Administration has granted full approval to Moderna’s coronavirus vaccine, the agency announced Monday.

Moderna’s vaccine, now known as Spikevax, was previously available under emergency use authorization and is the second coronavirus vaccine to get full FDA approval. Pfizer and BioNTech’s product was approved in August.

Moderna, a biotechnology company, said Monday that Spikevax has been approved by regulators in more than 70 countries and that more than 800 million doses were shipped worldwide last year.

Read the full article.

Moderna’s Covid vaccine has received full approval from the U.S. FDA for people 18 and older, an important milestone that bolsters the shot’s use as a major weapon against the virus https://t.co/JAoJxJ2R9n

— Bloomberg (@business) January 31, 2022